ATE442849T1 - Wässrige zusammensetzung mit einem thiazol- derivat - Google Patents
Wässrige zusammensetzung mit einem thiazol- derivatInfo
- Publication number
- ATE442849T1 ATE442849T1 AT05721534T AT05721534T ATE442849T1 AT E442849 T1 ATE442849 T1 AT E442849T1 AT 05721534 T AT05721534 T AT 05721534T AT 05721534 T AT05721534 T AT 05721534T AT E442849 T1 ATE442849 T1 AT E442849T1
- Authority
- AT
- Austria
- Prior art keywords
- aqueous composition
- thiazole derivative
- composition containing
- sup
- sugar
- Prior art date
Links
- 150000007979 thiazole derivatives Chemical class 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000000654 additive Substances 0.000 abstract 1
- 230000000996 additive effect Effects 0.000 abstract 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 abstract 1
- 239000004327 boric acid Substances 0.000 abstract 1
- 229920005862 polyol Polymers 0.000 abstract 1
- 150000003077 polyols Chemical class 0.000 abstract 1
- 150000005846 sugar alcohols Chemical class 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55395604P | 2004-03-18 | 2004-03-18 | |
| PCT/JP2005/005607 WO2005089755A1 (en) | 2004-03-18 | 2005-03-18 | Aqueous composition comprising thiazole derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE442849T1 true ATE442849T1 (de) | 2009-10-15 |
Family
ID=34961865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05721534T ATE442849T1 (de) | 2004-03-18 | 2005-03-18 | Wässrige zusammensetzung mit einem thiazol- derivat |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20070208068A1 (de) |
| EP (1) | EP1737450B1 (de) |
| JP (2) | JP4881159B2 (de) |
| KR (1) | KR101206319B1 (de) |
| CN (1) | CN1933833B (de) |
| AT (1) | ATE442849T1 (de) |
| CA (1) | CA2558135C (de) |
| DE (1) | DE602005016659D1 (de) |
| ES (1) | ES2331890T3 (de) |
| TW (1) | TWI339659B (de) |
| WO (1) | WO2005089755A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040033228A1 (en) | 2002-08-16 | 2004-02-19 | Hans-Juergen Krause | Formulation of human antibodies for treating TNF-alpha associated disorders |
| WO2006011631A2 (en) * | 2004-07-27 | 2006-02-02 | Astellas Pharma Inc. | Thiazole derivatives having vap-1 inhibitory activity |
| TW200835687A (en) * | 2006-11-30 | 2008-09-01 | R Tech Ueno Ltd | Thiazole derivatives and their use as VAP-1 inhibitor |
| US20100210697A1 (en) * | 2007-10-19 | 2010-08-19 | R-Tech Ueno, Ltd. | Pharmaceutical composition for treatment of cataract |
| TWI437986B (zh) * | 2008-01-31 | 2014-05-21 | R Tech Ueno Ltd | 噻唑衍生物及使用該衍生物作為ｖａｐ－１抑制劑之用途 |
| UA112154C2 (uk) | 2009-09-08 | 2016-08-10 | Біоті Терапіс Корп. | Застосування повністю людського анти-vap-1-антитіла для лікування фіброзних станів |
| AU2011293201B2 (en) * | 2010-08-27 | 2015-11-05 | Calcimedica Inc. | Compounds that modulate intracellular calcium |
| AU2014279863A1 (en) | 2013-06-12 | 2016-01-28 | Proximagen Limited | New therapeutic uses of enzyme inhibitors |
| EP3116503A4 (de) * | 2014-03-14 | 2017-08-23 | Aerpio Therapeutics, Inc. | Hptp-beta-hemmer |
| WO2015189534A1 (en) | 2014-06-12 | 2015-12-17 | Proximagen Limited | Vap-1 inhibitors for treating muscular dystrophy |
| EP3233762B1 (de) * | 2014-12-18 | 2024-09-11 | Basaran, Mustafa | Organisches und anorganisches düngemittel für bewässerungslandwirtschaft und mit nitrifikationshemmendem mittel und bor |
| AU2016366635A1 (en) | 2015-12-07 | 2018-06-21 | Benevolentai Cambridge Limited | VAP-1 inhibitors for treating pain |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0696533B2 (ja) * | 1987-01-14 | 1994-11-30 | 北陸製薬株式会社 | キノロンカルボン酸の水性組成物 |
| CA2125060C (en) * | 1993-07-02 | 1999-03-30 | Henry P. Dabrowski | Ophthalmic solution for artificial tears |
| CA2276034A1 (en) * | 1996-12-23 | 1998-07-02 | Mimi Lifen Quan | Oxygen or sulfur containing 5-membered heteroaromatics as factor xa inhibitors |
| AR002194A1 (es) * | 1997-03-17 | 1998-01-07 | Sanchez Reynaldo Alemany | Instrumento computarizado para el analisis del movimiento. |
| ATE391492T1 (de) * | 1997-07-29 | 2008-04-15 | Alcon Lab Inc | Ophthalmische zusammensetzungen enthaltend galaktomannanpolymere und borat |
| CN1440383A (zh) * | 2000-04-28 | 2003-09-03 | 三共株式会社 | PPARγ调制剂 |
| JP2002179572A (ja) * | 2000-10-06 | 2002-06-26 | Nikken Chem Co Ltd | アレルギー性眼疾患治療剤 |
| CN100491361C (zh) * | 2003-01-27 | 2009-05-27 | 安斯泰来制药有限公司 | 噻唑衍生物及其作为vap-1抑制剂的用途 |
| TWI336696B (en) * | 2003-01-27 | 2011-02-01 | Astellas Pharma Inc | Thiazole derivatives |
| CN1794988B (zh) * | 2003-03-31 | 2010-07-28 | 株式会社·R-技术上野 | 用于治疗血管渗透性过高疾病的组合物 |
-
2005
- 2005-03-18 JP JP2006529411A patent/JP4881159B2/ja not_active Expired - Fee Related
- 2005-03-18 TW TW094108308A patent/TWI339659B/zh not_active IP Right Cessation
- 2005-03-18 US US10/591,986 patent/US20070208068A1/en not_active Abandoned
- 2005-03-18 DE DE602005016659T patent/DE602005016659D1/de not_active Expired - Lifetime
- 2005-03-18 ES ES05721534T patent/ES2331890T3/es not_active Expired - Lifetime
- 2005-03-18 AT AT05721534T patent/ATE442849T1/de not_active IP Right Cessation
- 2005-03-18 CA CA2558135A patent/CA2558135C/en not_active Expired - Fee Related
- 2005-03-18 KR KR1020067019065A patent/KR101206319B1/ko not_active Expired - Fee Related
- 2005-03-18 CN CN2005800084472A patent/CN1933833B/zh not_active Expired - Fee Related
- 2005-03-18 WO PCT/JP2005/005607 patent/WO2005089755A1/en not_active Ceased
- 2005-03-18 EP EP05721534A patent/EP1737450B1/de not_active Expired - Lifetime
-
2011
- 2011-09-06 JP JP2011194023A patent/JP2012001555A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP1737450A1 (de) | 2007-01-03 |
| DE602005016659D1 (de) | 2009-10-29 |
| KR20060128011A (ko) | 2006-12-13 |
| JP2007529413A (ja) | 2007-10-25 |
| TWI339659B (en) | 2011-04-01 |
| ES2331890T3 (es) | 2010-01-19 |
| CA2558135A1 (en) | 2005-09-29 |
| US20070208068A1 (en) | 2007-09-06 |
| WO2005089755A1 (en) | 2005-09-29 |
| CA2558135C (en) | 2012-08-14 |
| CN1933833B (zh) | 2011-09-07 |
| EP1737450B1 (de) | 2009-09-16 |
| CN1933833A (zh) | 2007-03-21 |
| JP4881159B2 (ja) | 2012-02-22 |
| TW200531967A (en) | 2005-10-01 |
| KR101206319B1 (ko) | 2012-11-29 |
| JP2012001555A (ja) | 2012-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY157871A (en) | Mapk/erk kinase inhibitors | |
| WO2008081096A3 (fr) | Derives quinolinyliques, leur procede de preparation. les compositions pharmaceutiques qui les contiennent et leur utilisation comme agents hypoglycemiants et hypoli pemiants | |
| GB0418900D0 (en) | Novel salt forms | |
| MY140841A (en) | Indozolone derivatives as 11b-hsd1 inhibitors | |
| TH121482A (th) | องค์ประกอบทางเภสัชกรรมที่ประกอบด้วยอนุพันธ์ของควิโนลีน | |
| ATE442849T1 (de) | Wässrige zusammensetzung mit einem thiazol- derivat | |
| MXPA05011411A (es) | 1,4-diazepinas sustituidas y usos de las mismas. | |
| YU48803A (sh) | Derivati tetrahidropiridina,njihovo dobijanje i primena kao inhibitora za proliferaciju ćelija | |
| NZ524559A (en) | 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors | |
| WO2009025239A1 (ja) | 新規外用剤 | |
| AR041053A1 (es) | Derivados de dioxan-2-alquilcarbamatos, su preparacion y su aplicacion de terapeutica | |
| GEP20115166B (en) | 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS | |
| TNSN06338A1 (en) | Substantially pure 2-{[2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5-carbonyl]-amino}-3-(phenylpyridin-2-yl-amino)-propionic acid as an ikb kinase inhibitor | |
| EA200600878A1 (ru) | Производные феноксиуксусных кислот, применимые в качестве двойных агонистов активируемого пероксисомным пролифератором рецептора ( ppar ) | |
| MY146042A (en) | Water-soluble benzoazepine compound and its pharmaceutical composition | |
| BRPI0411664A (pt) | composição oral antiplaca aquosa estável | |
| EA200101230A1 (ru) | Новые ингибиторы металлопротеаз, метод их получения и содержащие их фармацевтические композиции | |
| WO2002004598A3 (en) | Improvement of cell culture performance by inhibitors of pyruvate dehydrogenase kinase | |
| WO2005097100A3 (en) | Antibacterial agents | |
| GEP20074256B (en) | Novel benzothiadiazine, process for their preparation and pharmaceutical compositions containing | |
| WO2005001009A8 (en) | Detergent formulations containing alkaline peroxide salts and organic acids | |
| ECSP088170A (es) | Derivados de 5-piridinil-1-azabiciclo[3.2.1]octano, su preparación y su aplicación en terapéutica | |
| TNSN08026A1 (en) | Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics | |
| DE60335960D1 (de) | 1,2,4-triazolderivat, verfahren zu dessenherstellung, und dieses enthaltende pharmazeutische zusammensetzung | |
| ATE374751T1 (de) | 3,4-dihydro-1h-chinolin-2-onderivate als norepinephrin-wiederaufnahme-hemmern |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |